You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Bulk Pharmaceutical API Sources for PROMETRIUM


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for PROMETRIUM

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Get Started Free P0130_SIGMA ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free P3972_SIGMA ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free P6149_SIGMA ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free P8783_SIGMA ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free P7556_SIGMA ⤷  Get Started Free
TCI (Tokyo Chemical Industry) ⤷  Get Started Free P0478 ⤷  Get Started Free
Molport ⤷  Get Started Free MolPort-001-794-643 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for: PROMETRIUM

Last updated: July 29, 2025

Introduction

Prometrium, marketed primarily under the brand name, is a pharmaceutical product composed of natural progesterone used in hormone replacement therapy, fertility management, and menstrual irregularities. As a hormone-based medication, its efficacy hinges crucially on the quality of its active pharmaceutical ingredient (API). This article reviews the global landscape of bulk API sources for Prometrium, emphasizing sourcing strategies, supplier credibility, regulatory compliance, and supply chain considerations.


Overview of Prometrium and API Requirements

Prometrium's API is pharmaceutical-grade progesterone, typically derived via biological fermentation of plant-based sterols or synthetically manufactured through chemical synthesis. The API must meet strict regulatory standards, including those mandated by the United States Food and Drug Administration (FDA), European Medicines Agency (EMA), and other relevant authorities.

High-purity progesterone requires rigorous quality control, traceability, and consistent supply. Ensuring reliable sourcing of bulk API involves engaging with reputable manufacturers capable of manufacturing pharmaceutical-grade progesterone under Good Manufacturing Practices (GMP).


Global API Manufacturing Regions and Leading Suppliers

1. North America

The United States and Canada host several prominent API producers specializing in steroid hormones, including progesterone:

  • ASK Chemicals: A division of Ashland Inc., they manufacture bulk progesterone suitable for pharmaceutical applications. Their facilities are GMP-compliant, providing high-quality APIs.

  • BASF: Offers pharmaceutical-grade progesterone with comprehensive regulatory documentation. Their global manufacturing network ensures supply stability.

2. Europe

European manufacturers are renowned for their strict regulatory oversight and high manufacturing standards:

  • Siegfried AG: Based in Switzerland, Siegfried is a leader in steroid hormone APIs, including progesterone, leveraging advanced synthesis and purification technology.

  • Segetis (formerly part of Merck): Known for high-purity steroid intermediates and APIs, with extensive regulatory approvals.

  • Baxter Healthcare: A global pharmaceutical manufacturer with GMP-certified facilities producing progesterone APIs.

3. Asia-Pacific

The Asia-Pacific region has significantly expanded its pharmaceutical manufacturing base:

  • WuXi AppTec (China): Offers CDMO services including steroid hormone synthesis with GMP certification; supplies bulk progesterone APIs.

  • Hainan Zhanjiang Pharmaceutical Co., Ltd. (China): Produces pharmaceutical-grade progesterone APIs, primarily for domestic markets, with increasing international capabilities.

  • Yunnan Baiyao Group (China): Engages in steroid API manufacturing, including progesterone, with growing GMP compliance.

4. India

India's API manufacturing industry has emerged as a dependable source of steroid hormones:

  • Macleods Pharmaceuticals: Produces progesterone APIs under GMP, serving both domestic and export markets.

  • Suven Life Sciences: Offers bulk progesterone with regulatory compliance aimed at global markets.

  • Strides Pharma Science: Provides GMP-grade progesterone APIs, leveraging cost advantages without compromising quality.


Factors Influencing API Sourcing Decisions for Prometrium

  • Regulatory Compliance: The API supplier must adhere to GMP standards and possess requisite regulatory approvals to ensure quality and facilitate global submissions.

  • Quality Assurance: Certificates of Analysis (CoA), batch consistency, and purity levels are critical. Suppliers with a proven track record mitigate risks of supply chain disruptions and quality failures.

  • Supply Chain Reliability: Geographic diversification reduces dependency on single sources, thus enhancing resilience against geopolitical, logistical, or pandemic-related disruptions.

  • Cost and Lead Times: Competitive pricing and scalable production capacity influence procurement strategies, particularly for large-volume orders.

  • Intellectual Property and Confidentiality: Ensuring proprietary formulations or synthesis routes are protected when partnering with foreign manufacturers.


Regulatory and Certification Considerations

API suppliers for Prometrium must comply with relevant global regulations, including:

  • GMP Certification: From recognized authorities such as the FDA, EMA, or WHO.

  • Qualified Person (QP) Certification: Required for API batch releases within the EU.

  • Certificate of Suitability (CEP): Issued by the EDQM (European Directorate for the Quality of Medicines & HealthCare) to authenticate API quality.

  • Plant and Process Validation Documentation: To ensure manufacturing consistency and compliance.


Emerging Trends and Future Outlook

The increasing demand for bioidentical hormone therapies and personalized medicine sustains a steady market for progesterone APIs. Moreover, advances in synthetic biology and green chemistry are poised to transform manufacturing processes, enabling more sustainable and cost-effective API production.

Expanding GMP-certified facilities in emerging regions, coupled with stricter regulatory harmonization, is expected to enhance supply security. Companies investing in quality, technological innovation, and secure supply chains will likely dominate the future API sourcing landscape.


Conclusion

Reliable sourcing of pharmaceutical-grade progesterone API remains central to the manufacturing of Prometrium. Leading global suppliers span North America, Europe, Asia-Pacific, and India, each offering distinct advantages in quality, regulatory compliance, and cost. Strategic partnerships, qualified manufacturing practices, and diversified supply chains are essential to meet market demands and ensure consistent product quality.


Key Takeaways

  • Procurement of the API for Prometrium should prioritize GMP-compliant sources with verifiable regulatory certifications.
  • The supply chain is geographically diversified; manufacturers from North America, Europe, and Asia-Pacific present robust options.
  • Quality assurance, traceability, and consistent supply are non-negotiable factors influencing supplier choices.
  • Innovations in synthetic biology and sustainable manufacturing are shaping future API sourcing strategies.
  • Maintaining ongoing regulatory compliance and validation processes minimizes market access risks.

FAQs

1. What are the main sources of progesterone API globally?
Major sources include manufacturers in North America (e.g., ASK Chemicals, BASF), Europe (e.g., Siegfried AG), and Asia-Pacific (e.g., WuXi AppTec, Chinese pharmaceutical firms). India is also a strong player, with companies like Macleods and Suven.

2. How do I assess the credibility of an API supplier for Prometrium?
Evaluate GMP certification, regulatory approvals, batch-to-batch consistency, QC documentation, supply history, and customer references. Engaging with suppliers holding CEPs or other recognized certifications adds confidence.

3. What regulatory requirements apply to API sourcing for Prometrium?
Manufacturers must comply with GMP standards, hold relevant certifications (e.g., CEP), and ensure documentation such as Certificates of Analysis, validation reports, and regulatory dossiers are in place.

4. How does geographic diversification impact API supply security?
Diversification reduces dependency on a single region, mitigates risks from geopolitical events, pandemics, or natural disasters, and enhances overall supply resilience.

5. What future trends influence API sourcing for hormone therapies like Prometrium?
Emerging trends include sustainable manufacturing processes, bio-based synthesis, stricter regulatory landscapes, and integrated supply chain management leveraging digital technologies.


References

  1. [1] European Directorate for the Quality of Medicines & HealthCare. Certificate of Suitability (CEP) Program.
  2. [2] U.S. Food and Drug Administration. Good Manufacturing Practices.
  3. [3] Pharmaceutical Technology. Steroid hormone APIs: Market overview and supplier landscape.
  4. [4] WHO Technical Report Series. Good Manufacturing Practices for Bulk Pharmaceutical Substances.
  5. [5] Market analyses from IQVIA and Evaluate Pharma reports on hormone API trends.

Note: The above sources encompass publicly available data, industry reports, and regulatory standards relevant to API sourcing for Prometrium.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.